Medication, honestly
Starting ADHD medication: what the first thirty days are actually like
Most people arrive at this decision having read the worst version of it. Personality changes, zombie children, something you can never stop. The reality is both more ordinary and more adjustable than that, and knowing the shape of the first month removes most of the fear.
Here is what actually happens, what is common, what is worth a phone call, and what “it stopped working” usually turns out to mean.
The first thing to understand: it is a process, not a prescription
Nobody can predict the right medication or the right dose for a particular person in advance. There is no blood test and no scan that gives the answer. What there is instead is a structured trial: start low, increase slowly, watch closely, and adjust.
That is why the first month involves more contact than people expect. If a clinician writes a prescription and books you back in three months, that is not careful prescribing. The early weeks are where the actual work happens.
It also means an unsuccessful first attempt is information, not failure. People frequently need a different dose, a different release formulation, or a different medication class before it settles, and none of that means treatment will not work.
Week by week
The first few days
Stimulants work quickly. Unlike antidepressants, there is no multi-week wait to find out whether anything is happening. You often know within hours of a dose whether it did something.
What a good response looks like is quieter than people expect. Not euphoria and not a personality change. Usually it is described as being able to start the thing, or noticing the background noise has dropped, or getting to the end of a page. Parents often say their child seemed more like themselves, not less.
If someone feels flattened, robotic, or unlike themselves, that is not the target and it is not something to endure. It usually means the dose is too high or the medication is not the right one.
Weeks one and two
This is where the common early side effects show up. Headache, stomach ache, and nausea are frequent, and most of them settle within the first week or two without anything being changed.
Appetite suppression is the most common effect of all, reported by a large majority of people taking stimulants. It often eases after the first two or three weeks, and when it does not, it is usually manageable by changing when the dose is taken, eating a substantial breakfast before it takes effect, and moving the largest meal to the evening when the medication has worn off.
Sleep is the other one to watch. Difficulty falling asleep is common early on and frequently responds to taking the dose earlier in the day or switching formulation. Worth knowing: untreated ADHD also disrupts sleep, so some people sleep better on treatment rather than worse.
Weeks three and four
By now the dose is usually being adjusted based on what the first weeks showed. This is the point where the picture is clear enough to know whether the direction is right.
It is also when rebound tends to be noticed.
Rebound, explained
As a dose wears off, some people experience a sharp drop: irritability, tearfulness, a crash in energy, sudden intense hunger. With children this often lands in the late afternoon, and parents reasonably worry the medication is making their child worse.
It usually is not a sign the medication is wrong. It is a sign of how it is leaving the system, and it commonly responds to a change in formulation, timing, or the way the dose is structured across the day. Report it rather than tolerating it.
What gets monitored, and why
These are the things that should be checked at baseline, after dose changes, and then periodically:
- Blood pressure and heart rate. Stimulants raise both, though on average by small amounts, in the region of 1 to 2 beats per minute and 3 to 4 mmHg. Small average changes still need checking, because averages do not describe individuals, and because a personal or family history of cardiac problems changes the calculation.
- Height and weight, for children. Appetite suppression is common enough that growth is tracked directly rather than assumed to be fine.
- Sleep. Both because medication affects it and because poor sleep produces inattention that can be mistaken for an inadequate dose.
- Mood and anxiety. Stimulants can increase anxiety or irritability in some people, and that needs distinguishing from rebound and from an underlying anxiety disorder.
- Whether it is actually helping. Rating scales completed by the people who see the person daily, at home and at school or work. Impressions in an office are not enough.
On ECGs. A routine ECG before starting is not required for otherwise healthy people. It is indicated when history or examination suggests a reason for it. If a clinician orders one, they should be able to tell you which specific risk factor prompted it.
The growth question, answered honestly
This is the concern parents raise most, and it deserves a straight answer rather than reassurance.
Some children, particularly in the first year of treatment, grow more slowly than expected. Studies generally find growth rate returning toward normal in the second and third years, and evidence of catch-up after stopping. Estimates of the effect on eventual adult height are small, commonly put at around half an inch to an inch, and the research is genuinely mixed rather than settled.
The practical answer is that this is why height and weight are plotted at every visit instead of being discussed in the abstract. If growth flattens, that is a finding, and it is acted on. It is a reason for monitoring, not a reason to refuse treatment, and equally not something to wave away.
“It worked for a month and then stopped”
Common, and usually not what it appears to be. True tolerance to stimulants is less frequent than people assume. The more likely explanations, roughly in order:
- Sleep has slipped. The most common one by a distance, and it undoes everything else.
- The demands changed. A new term, a promotion, a new baby. The medication is doing the same thing against a heavier load.
- The timing is wrong. Coverage is ending before the day does, so the hardest part of the day is unmedicated.
- Expectations recalibrated. After a few good weeks the improvement becomes the new normal and stops feeling like anything. This is worth naming, because it makes people stop a treatment that is working.
- Something else has arrived. Depression and anxiety both impair concentration and both are common alongside ADHD.
Each of those leads somewhere different. Increasing the dose is one option among several, and frequently not the right first move.
Medication is not the only thing on the table
Non-stimulant options exist and are the better choice for some people, including where there is significant anxiety, a history of substance use, intolerable stimulant side effects, or a simple preference not to take a controlled medication. They work differently, they take weeks rather than hours to show an effect, and they are a legitimate first choice rather than a consolation.
Beyond medication, structural changes, skills work, and accommodations at school or work carry real weight. Medication tends to make those approaches possible rather than replacing them. Anyone presenting a prescription as the entire treatment plan is not describing good care.
The practical part nobody mentions
Stimulants are controlled substances, and that has consequences worth knowing before you start:
- Prescriptions are typically issued a month at a time, with no automatic refills
- Running out early, losing a prescription, or filling late is genuinely difficult to resolve, so the calendar matters
- Supply shortages have been an ongoing problem, and it is worth asking a pharmacy about stock before assuming a prescription can be filled the same day
- Plan for the transition if you move, change insurance, or go to university out of state
Questions worth asking before you start
- What are we hoping this improves, specifically, and how will we know?
- How often will we meet during the first two months?
- What side effects should prompt a call rather than waiting for the next appointment?
- What is the plan if the first medication does not suit?
- What will you monitor, and how often?
A clinician who answers those clearly is telling you something useful about how the rest of the treatment will go. More on how we approach evaluation in this article on adult ADHD, and our published rates are on the fees page.
Sources
- Early side effects, appetite, sleep, rebound and growth: Child Mind Institute and the American Academy of Pediatrics ADHD clinician toolkit.
- Cardiovascular monitoring and average blood pressure and heart rate changes: CHADD, Cardiovascular Risk and Stimulant Medication.
- ECG guidance: AAP and AHA joint clarification.
- Diagnostic framework: American Psychiatric Association, DSM-5-TR.